HF
PRCT icon

HRT Financial’s Procept Biorobotics PRCT Stock Holding History

HRT Financial’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25M Buy
144,093
+118,367
+460% +$2.96M 0.01% 1408
2026
Q1 		$643K Sell
25,726
-44,146
-63% -$1.24M ﹤0.01% 2338
2025
Q4 		$2.2M Buy
+69,872
New +$2.32M 0.01% 1242
2022
Q2 		– Sell
-51,282
Closed -$1.79M – 3564
2022
Q1 		$1.79M Buy
+51,282
New +$1.23M 0.01% 692

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HRT Financial's PRCT Position: Q2 2026 in Review

HRT Financial increased its Procept Biorobotics (PRCT) stake by 460% in Q2 2026, buying an estimated $2.96M and bringing the position to 144,093 shares worth $3.25M. The position accounts for 0.01% of the portfolio, ranked #1408.

HRT Financial first reported a position in PRCT in Q1 2022 and has held it in 4 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • HRT Financial held 144,093 shares of Procept Biorobotics worth $3.25M as of Q2 2026.
  • HRT Financial bought 118,367 Procept Biorobotics shares in Q2 2026, an estimated $2.96M.
  • Procept Biorobotics made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1408 holding.
  • HRT Financial first reported a position in Procept Biorobotics in Q1 2022 and has held it in 4 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.